Cargando…
Astaxanthin-loaded polymer-lipid hybrid nanoparticles (ATX-LPN): assessment of potential otoprotective effects
BACKGROUND: Ototoxicity is one of the major side effects of platinum-based chemotherapy, especially cisplatin therapy. To date, no FDA approved agents to alleviate or prevent this ototoxicity are available. However, ototoxicity is generally believed to be produced by excessive generation of reactive...
Autores principales: | Gu, Jiayi, Chen, Yuming, Tong, Ling, Wang, Xueling, Yu, Dehong, Wu, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081530/ https://www.ncbi.nlm.nih.gov/pubmed/32192504 http://dx.doi.org/10.1186/s12951-020-00600-x |
Ejemplares similares
-
Correction to: Astaxanthin-loaded polymer-lipid hybrid nanoparticles (ATX-LPN): assessment of potential otoprotective effects
por: Gu, Jiayi, et al.
Publicado: (2020) -
An enhanced antioxidant strategy of astaxanthin encapsulated in ROS-responsive nanoparticles for combating cisplatin-induced ototoxicity
por: Gu, Jiayi, et al.
Publicado: (2022) -
The Use of Nanoparticles in Otoprotection
por: Barbara, Maurizio, et al.
Publicado: (2022) -
Persistence of the otoprotective effect. How long does otoprotection against amikacin lasts?
por: de Oliveira, Andreia Ardevino, et al.
Publicado: (2015) -
Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity
por: Chen, Yuming, et al.
Publicado: (2019)